Electronic Supplementary Material (ESI) for Biomaterials Science. This journal is © The Royal Society of Chemistry 2018 Fig. 1 . Polymerization solutions were vortexed, transferred to septa-sealed round bottom flasks, purged under N 2 for 30 min and incubated in a 90 °C water bath for 8 h. The resultant polymers were purified by dialysis against acetone for two days and then isolated by further dialysis against water in Spectra/Por dialysis tubing (MWCO 6-8 kDa). The final polymers were then lyophilized for further use.
To synthesize the mannose-containing block, mannose functionalized with ethyl methacrylate (ManEMA) was synthesized and fully characterized as described previously 1 . The synthesized ManEMA monomers with acetyl protecting groups (1g, 480 mM) were added to the macroCTA (1.1g, 38.4 mM) and dissolved in dioxane. 4,4-azobis(4-cyanovaleric acid) (ABCVA) was used as the radical initiator. Following the addition of ABCVA the solution was purged with nitrogen for 30 min and allowed to polymerize at 70 °C for 18 h. The resulting diblock copolymer was obtained via precipitation in diethyl ether (6x) and placed in vacuum overnight. To deprotect acetyl groups on ManEMA monomers, the obtained diblock copolymer was added to a solution of 1 wt% sodium methoxide in methanol at a copolymer concentration of 50 mg/mL. After 1 h incubation at room temperature, the solution was quenched and neutralized with acetic acid to a pH 7 and dialyzed against deionized water. The solution was then lyophilized to obtain the final deprotected glycopolymer, poly[(DEAEMA-co-BMA)-b-ManEMA].
Characterization of diblock copolymer by SEC-GPC and NMR
The compositions of the macroCTA and the diblock copolymer were determined by 1 H-NMR (Bruker DRX499) in deuterated dimethylsulfoxide (DMSO-d 6 ) at 25 °C. The number average molecular weight (M n ) and dispersity (Đ) were measured by GPC using Tosoh SEC TSK GEL α-3000 and α-4000 columns (Tosoh Bioscience, Montgomeryville, PA) connected in series to a 1200 Series liquid chromatography system (Agilent, Santa Clara, CA) and a miniDAWN TREOS three-angle light scattering instrument with an Optilab TrEX refractive index detector (Wyatt Technology, Santa Barbara, CA).
High-performance size exclusion chromatography (HPSEC)
Incorporation of poly[(DEAEMA-co-BMA)-b-ManEMA] with liposomes was examined using HPSEC 2 . This analysis was performed with a HPLC (Agilent 1260 series HPLC, USA) equipped with an Acclaim™ SEC-1000 LC Column (7.8 mm × 150 mm, 7 µm ThermoFisher). The eluent was PBS and the flow rate was 1 mL/min. Diluted polymer solution or rhodamine-labeled PALs in 10-µL aliquots were injected. The elution was followed by absorbance (λ= 310 nm) and fluorescence measurement (Ex. 560 nm, Em. 580 nm) to detect the polymer and rhodamine-labeled liposomes, respectively.
MTS assay
Cell viability of the polymer alone or PALs with streptomycin encapsulation was evaluated by MTS assay in a murine macrophage cell line, RAW 264.7. Culture condition of RAW 264.7 cells was DMEM supplemented with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin in a 37°C, 5% CO 2 incubator. The RAW 264.7 cells were seeded into 96-well plates at a density of 50,000 cells per well in 100 µL DMEM supplemented with 10% fetal bovine serum (FBS) in 5% CO 2 incubator at 37 °C. After 16-18 h, cells were incubated with the polymer or PALs (100 µL per well) at a series of PAL concentrations (polymer + lipid). After continued incubation for 24 h, the effect of different treatments on cell viability was assessed by the MTS assay. The absorbance at 490 nm in each well was determined by a microplate reader (Tecan Safire2). Untreated cells were used as a control with 100% viability. The relative cell viability (%) compared to control cells was calculated by (A sample /A control ) × 100. All treatments were done in triplicates. 
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